198 related articles for article (PubMed ID: 25267661)
1. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
Hanboonkunupakarn B; Ashley EA; Jittamala P; Tarning J; Pukrittayakamee S; Hanpithakpong W; Chotsiri P; Wattanakul T; Panapipat S; Lee SJ; Day NP; White NJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7340-6. PubMed ID: 25267661
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
Jittamala P; Pukrittayakamee S; Ashley EA; Nosten F; Hanboonkunupakarn B; Lee SJ; Thana P; Chairat K; Blessborn D; Panapipat S; White NJ; Day NP; Tarning J
Antimicrob Agents Chemother; 2015 Jan; 59(1):505-13. PubMed ID: 25385096
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
Chotsiri P; Wattanakul T; Hoglund RM; Hanboonkunupakarn B; Pukrittayakamee S; Blessborn D; Jittamala P; White NJ; Day NPJ; Tarning J
Br J Clin Pharmacol; 2017 Dec; 83(12):2752-2766. PubMed ID: 28695570
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
Rijken MJ; McGready R; Phyo AP; Lindegardh N; Tarning J; Laochan N; Than HH; Mu O; Win AK; Singhasivanon P; White N; Nosten F
Antimicrob Agents Chemother; 2011 Dec; 55(12):5500-6. PubMed ID: 21947392
[TBL] [Abstract][Full Text] [Related]
7. Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults.
Hanboonkunupakarn B; van der Pluijm RW; Hoglund R; Pukrittayakamee S; Winterberg M; Mukaka M; Waithira N; Chotivanich K; Singhasivanon P; White NJ; Dondorp AM; Tarning J; Jittamala P
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182525
[TBL] [Abstract][Full Text] [Related]
8. Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Sutanto I; Soebandrio A; Ekawati LL; Chand K; Noviyanti R; Satyagraha AW; Subekti D; Santy YW; Crenna-Darusallam C; Instiaty I; Budiman W; Prasetya CB; Lardo S; Elyazar I; Duparc S; Cedar E; Rolfe K; Fernando D; Berni A; Jones S; Kleim JP; Fletcher K; Sharma H; Martin A; Taylor M; Goyal N; Green JA; Tan LK; Baird JK
Lancet Infect Dis; 2023 Oct; 23(10):1153-1163. PubMed ID: 37236221
[TBL] [Abstract][Full Text] [Related]
9. Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.
Reuter SE; Evans AM; Shakib S; Lungershausen Y; Francis B; Valentini G; Bacchieri A; Ubben D; Pace S
Clin Drug Investig; 2015 Sep; 35(9):559-67. PubMed ID: 26293519
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.
Lon C; Manning JE; Vanachayangkul P; So M; Sea D; Se Y; Gosi P; Lanteri C; Chaorattanakawee S; Sriwichai S; Chann S; Kuntawunginn W; Buathong N; Nou S; Walsh DS; Tyner SD; Juliano JJ; Lin J; Spring M; Bethell D; Kaewkungwal J; Tang D; Chuor CM; Satharath P; Saunders D
PLoS One; 2014; 9(3):e93138. PubMed ID: 24667662
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Pharmacokinetics and Ex Vivo Antimalarial Activities of Artesunate-Amodiaquine and Artemisinin-Piperaquine in Healthy Volunteers for Preselection Malaria Therapy.
Quang NN; Chavchich M; Anh CX; Birrell GW; van Breda K; Travers T; Rowcliffe K; Edstein MD
Am J Trop Med Hyg; 2018 Jul; 99(1):65-72. PubMed ID: 29741150
[TBL] [Abstract][Full Text] [Related]
12. Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.
von Seidlein L; Hanboonkunupakarn B; Jittamala P; Pongsuwan P; Chotivanich K; Tarning J; Hoglund RM; Winterberg M; Mukaka M; Peerawaranun P; Sirithiranont P; Doran Z; Ockenhouse CF; Ivinson K; Lee C; Birkett AJ; Kaslow DC; Singhasivanon P; Day NPJ; Dondorp AM; White NJ; Pukrittayakamee S
Hum Vaccin Immunother; 2020; 16(1):33-41. PubMed ID: 31306084
[No Abstract] [Full Text] [Related]
13. Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs.
Chairat K; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Hanpithakpong W; Blessborn D; White NJ; Day NPJ; Tarning J
J Antimicrob Chemother; 2018 Nov; 73(11):3102-3113. PubMed ID: 30085149
[TBL] [Abstract][Full Text] [Related]
14. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
[TBL] [Abstract][Full Text] [Related]
15. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
[TBL] [Abstract][Full Text] [Related]
16. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Sutanto I; Tjahjono B; Basri H; Taylor WR; Putri FA; Meilia RA; Setiabudy R; Nurleila S; Ekawati LL; Elyazar I; Farrar J; Sudoyo H; Baird JK
Antimicrob Agents Chemother; 2013 Mar; 57(3):1128-35. PubMed ID: 23254437
[TBL] [Abstract][Full Text] [Related]
17. Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.
Kobylinski KC; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Pantuwatana K; Phasomkusolsil S; Davidson SA; Winterberg M; Hoglund RM; Mukaka M; van der Pluijm RW; Dondorp A; Day NPJ; White NJ; Tarning J
Clin Pharmacol Ther; 2020 May; 107(5):1221-1230. PubMed ID: 31697848
[TBL] [Abstract][Full Text] [Related]
18. Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial.
Dicko A; Brown JM; Diawara H; Baber I; Mahamar A; Soumare HM; Sanogo K; Koita F; Keita S; Traore SF; Chen I; Poirot E; Hwang J; McCulloch C; Lanke K; Pett H; Niemi M; Nosten F; Bousema T; Gosling R
Lancet Infect Dis; 2016 Jun; 16(6):674-684. PubMed ID: 26906747
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interactions between primaquine and chloroquine.
Pukrittayakamee S; Tarning J; Jittamala P; Charunwatthana P; Lawpoolsri S; Lee SJ; Hanpithakpong W; Hanboonkunupakarn B; Day NP; Ashley EA; White NJ
Antimicrob Agents Chemother; 2014 Jun; 58(6):3354-9. PubMed ID: 24687509
[TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
Awab GR; Pukrittayakamee S; Imwong M; Dondorp AM; Woodrow CJ; Lee SJ; Day NP; Singhasivanon P; White NJ; Kaker F
Malar J; 2010 Apr; 9():105. PubMed ID: 20409302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
